Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Kuhns

Dentist, Oral and Maxillofacial Surgery Mount Dora, FL Doctor of Dentistry

NPI 1871856625 CMS profile 130759

2023 W Old US Highway 441, Mount Dora, FL 32757

Open in the dashboard

General payments

$7,663

168 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Kuhns of Mount Dora, FL is reported in the CMS Open Payments database as having received $7,663 across 168 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,897 48
2024 General $619 31
2023 General $986 27
2022 General $913 48
2021 General $382 11
2019 General $1,866 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Kuhns
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Christopher Kuhns were reported at $2,897. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Christopher Kuhns Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $1,866 $142 $50–$420 $163
2020 $0 $96 $36–$277 $114
2021 $382 $138 $45–$419 $132
2022 $913 $144 $48–$367 $149
2023 $986 $153 $55–$399 $160
2024 $619 $152 $50–$400 $164
2025 $2,897 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Patterson Companies, Inc. $2,806 2 payments
  2. Zimvie Inc. $2,305 146 payments
  3. Medical Device Business Services, Inc. $1,831 1 payment
  4. Zimmer Biomet Holdings, Inc. $536 13 payments
  5. DePuy Synthes Sales Inc. $94 1 payment
  6. Geistlich Pharma, North America, Inc. $36 2 payments
  7. Henry Schein, Inc. $35 2 payments
  8. AxoGen $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,026 165 payments
  2. Long term medical supply or device loan $2,306 1 payment
  3. Travel and Lodging $1,831 1 payment
  4. Education $500 1 payment
Products named General payments · program years 2019–2025
  1. Dentronix $2,306 1 payment
  2. T3 Dental $1,127 48 payments
  3. 3i T3 $633 46 payments
  4. All T3 Implants $290 7 payments
  5. Diem2-RevitaliZe $219 35 payments
  6. T3 Dental $154 2 payments
  7. TSX Implants $144 6 payments
  8. TRUMATCH $94 1 payment
  9. Bellatek $81 4 payments
  10. Regen Procedure Instruments $45 2 payments
  11. Other $192 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

1,021

Median for Oral Surgery (Dentist only): 288

Drug cost

$4,466

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

18.8%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 313 $1,493
Amoxicillin Generic 354 $1,421
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 168 $659
Azithromycin Generic 72 $319
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 24 $242
Celecoxib Generic 20 $177
Tramadol Hcl Generic 58 $101
Clindamycin Hcl Generic 12 $54

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Records

168 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record